ATR regulates fragile site stability

Cell

Volumn 111, Issue 6, 2002, Pages 779-789

  Casper, Anne M ^a   Nghiem, Paul ^b,c,d   Arlt, Martin F ^a   Glover, Thomas W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM GENE; ATR GENE; CELL LINE; CHROMOSOME DELETION; CHROMOSOME FRAGILE SITE; CHROMOSOME REPLICATION; DNA REPLICATION; GENE; GENE REPLICATION; MAMMAL; METAPHASE CHROMOSOME; NONHUMAN; PRIORITY JOURNAL; REVIEW;

MAMMALIA;

EID: 0037074013     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)01113-3     Document Type: Article

References (64)

1. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15:2001;2177-2196.
2. Anton M., Graham F.L. Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein. a molecular switch for control of gene expression J. Virol. 69:1995;4600-4606.
3. Arlt M.F., Miller D.E., Beer D.G., Glover T.W. Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosomes Cancer. 33:2002;82-92.
4. Bednarek A., Keck-Waggoner C.L., Daniel R.L., Laflin K.J., Bergsagel P.L., Kiguchi K., Brenner A.W., Aldaz C.M. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res. 61:2001;8068-8073.
5. Bentley N.J., Holtzman D.A., Flaggs G., Keegan K.S., DeMaggio A., Ford J.C., Hoekstra M., Carr A.M. The Schizosaccharomyces pombe rad3 checkpoint gene. EMBO J. 15:1996;6641-6651.
6. Brown E.J., Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14:2000;397-402.
7. Cha R.S., Kleckner N. ATR homolog Mec1 promotes fork progression, thus averting breaks in replication slow zones. Science. 297:2002;602-606.
8. Cimprich K.A., Shin T.B., Keith C.T., Schreiber S.L. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc. Natl. Acad. Sci. USA. 93:1996;2850-2855.
9. Cliby W.A., Roberts C.J., Cimprich K.A., Stringer C.M., Lamb J.R., Schreiber S.L., Friend S.H. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J. 17:1998;159-169.
10. Coquelle A., Pipiras E., Toledo F., Buttin G., Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell. 89:1997;215-225.
11. Corbin S., Neilly M.E., Espinosa R. III, Davis E.M., McKeithan T.W., Le Beau M.M. Identification of unstable sequences within the common fragile site at 3p14.2. implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors Cancer Res. 62:2002;3477-3484.
12. Cortez D., Guntuku S., Qin J., Elledge S.J. Atr and atrip. partners in checkpoint signaling Science. 294:2001;1713-1716.
13. Dimitrova D.S., Gilbert D.M. Temporally coordinated assembly and disassembly of replication factories in the absence of DNA synthesis. Nat. Cell Biol. 2:2000;686-694.
14. Druck T., Hadaczek P., Fu T.-B., Ohta M., Siprashvili Z., Baffa R., Negrini M., Kastury K., Veronese M.L., Rosen D.et al. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res. 57:1997;504-512.
15. Dumon K.R., Ishii H., Fong L.Y.Y., Zanesi N., Fidanza V., Mancini R., Vecchione A., Baffa R., Trapasso F., During M.J.et al. FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc. Natl. Acad. Sci. USA. 98:2001;3346-3351.
16. Durocher D., Jackson S.P. DNA-PK, ATM and ATR as sensors of DNA damage. variations on a theme? Curr. Opin. Cell Biol. 13:2001;225-231.
17. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
18. Glover T.W. Instability at chromosomal fragile sites. Recent Results Cancer Res. 154:1998;185-199.
19. Glover T.W., Stein C.K. Induction of sister chromatid exchanges at common fragile sites. Am. J. Hum. Genet. 41:1987;882-890.
20. Glover T.W., Stein C.K. Chromosome breakage and recombination at fragile sites. Am. J. Hum. Genet. 43:1988;265-273.
21. Glover T.W., Berger C., Coyle J., Echo B. DNA polymerase α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 67:1984;136-142.
22. Glover T.W., Coyle-Morris J., Morgan R. Fragile sites. overview, occurrence in acute nonlymphocytic leukemia and effects of caffeine on expression Cancer Genet. Cytogenet. 19:1986;141-150.
23. Glover T.W., Hoge A.W., Miller D.E., Ascara-Wilke J.E., Adam A.N., Dagenais S.L., Wilke C.M., Dierick H.A., Beer D.G. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. Cancer Res. 58:1998;3409-3414.
24. Hammond E.M., Denko N.C., Dorie M.J., Abraham R.T., Giaccia A.J. Hypoxia links ATR and p53 through replication arrest. Mol. Cell. Biol. 22:2002;1834-1843.
25. Hansen R.S., Canfield T.K., Fjeld A.D., Mumm S., Laird C.D., Gartler S.M. A variable domain of delayed replication in FRAXA fragile X chromosomes. X inactivation-like spread of late replication Proc. Natl. Acad. Sci. USA. 94:1997;4587-4592.
26. Harborth J., Elbashir S.M., Bechert K., Tuschl T., Weber K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114:2001;4557-4565.
27. Hellman A., Rahat A., Scherer S.W., Darvasi A., Tsui L.-C., Kerem S. Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability. Mol. Cell. Biol. 20:2000;4420-4427.
28. Huang H., Reed C.P., Mordi A., Lomberk G., Wang L., Shridhar V., Hartmann L., Jenkins R., Smith D.I. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer. Genes Chromosomes Cancer. 24:1999;48-55.
29. Huebner K., Croce C.M. FRA3B and other common fragile sites. the weakest links Nat. Rev. Cancer. 1:2001;214-221.
30. Kondo T., Wakayama T., Naiki T., Matsumoto K., Sugimoto K. Recruitment of Mec1 and Ddc1 checkpoint proteins to double-strand breaks through distinct mechanisms. Science. 294:2001;867-870.
31. Le Beau M.M., Rassool F.V., Neilly M.E., Espinosa R. III, Glover T.W., Smith D.I., McKeithan T.W. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction. implications for the mechanism of fragile site induction Hum. Mol. Genet. 7:1998;755-761.
32. 2/M DNA damage checkpoint. Genes Dev. 14:2000;1448-1459.
33. Lopes M., Cotta-Ramusino C., Pellicioli A., Liberi G., Plevani P., Muzi-Falconi M., Newlon C.S., Foiani M. The DNA replication checkpoint response stabilizes stalled replication forks. Nature. 412:2001;557-561.
34. Marchetti M.A., Kumar S., Hartsuiker E., Maftahi M., Carr A.M., Freyer G.A., Burhans W.C., Huberman J.A. A single unbranched S-phase DNA damage and replication fork blockage checkpoint pathway. Proc. Natl. Acad. Sci. USA. 99:2002;7472-7477.
35. Masramon L., Ribas M., Cifuentes P., Arribas R., García F., Egozcue J., Peinado M.A., Miró R. Cytogenetic characterization of two colon cell lines by using conventional G-banding, comparative genomic hybridization, and whole chromosome painting. Cancer Genet. Cytogenet. 121:2000;17-21.
36. Michael D., Beer D.G., Wilke C.W., Miller D.E., Glover T.W. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene. 15:1997;1653-1659.
37. Mimori K., Druck T., Inoue H., Alder H., Berk L., Mori M., Huebner K., Croce C.M. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc. Natl. Acad. Sci. USA. 96:1999;7456-7461.
38. Mishmar D., Rahat A., Scherer S.W., Nyakatura G., Hinzmann B., Kohwi Y., Mandel-Gutfroint Y., Lee J.R., Drescher B., Sas D.E.et al. Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc. Natl. Acad. Sci. USA. 95:1998;8141-8146.
39. 1 checkpoint-deficient cells to lethal premature chromatin condensation. Proc. Natl. Acad. Sci. USA. 98:2001;9092-9097.
40. Nghiem P., Park P.K., Sim Y.-s., Desai B.N., Schreiber S.L. ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint. J. Biol. Chem. 277:2002;4428-4434.
41. Paige A.J.W., Taylor K.J., Stewart A., Sgouros J.G., Gabra H., Sellar G.C., Smyth J.F., Porteous D.J., Watson J.E.V. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res. 60:2000;1690-1697.
42. Paige A.J.W., Taylor K.J., Taylor C., Hillier S.G., Farrington S., Scott D., Porteous D.J., Smyth J.F., Gabra H., Watson J.E.V. Wwox. a candidate tumor suppressor gene involved in multiple tumor types Proc. Natl. Acad. Sci. USA. 98:2001;11417-11422.
43. 2 checkpoint and chromosomal damage in proliferating lymphocytes Mutagenesis. 16:2001;419-422.
44. Rassool F.V., McKeithan T.W., Neilly M.E., van Melle E., Espinosa R. III, Le Beau M.M. Preferential integration of marker DNA into the chromosomal fragile site at 3p14. an approach to cloning fragile sites Proc. Natl. Acad. Sci. USA. 88:1991;6657-6661.
45. Ried K., Finnis M., Hobson L., Mangelsdorf M., Sayan S., Nancarrow J.K., Woollatt E., Kremmidiotis G., Gardner A., Venter D.et al. Common chromosomal fragile site FRA16D sequence. identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells Hum. Mol. Genet. 9:2000;1651-1663.
46. Santocanale C., Diffley J.F. A Mec1- and Rad53-dependent checkpoint controls late-firing origins of DNA replication. Nature. 395:1998;615-618.
47. Sarkaria J.N., Busby E.C., Tibbetts R.S., Roos P., Taya Y., Karnitz L.M., Abraham R.T. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59:1999;4375-4382.
48. Shiraishi T., Druck T., Mimori K., Flomenberg J., Berk L., Alder H., Miller W., Huebner K., Croce C.M. Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit. Proc. Natl. Acad. Sci. USA. 98:2001;5722-5727.
49. Smeets D.F.C.M., van de Klundert F.A.J.M. Common fragile sites in man and three closely related primate species. Cytogenet. Cell Genet. 53:1990;8-14.
50. Sutherland G.R., Baker E., Richards R.I. Fragile sites still breaking. Trends Genet. 14:1998;501-506.
51. Telatar M., Wang Z., Udar N., Liang T., Bernatowska-Matuszkiewicz E., Lavin M., Shiloh Y., Concannon P., Good R.A., Gatti R.A. Ataxia-telangiectasia. mutations in ATM cDNA detected by protein-truncation screening Am. J. Hum. Genet. 59:1996;40-44.
52. Tercero J.A., Diffley J.F.X. Regulation of DNA replication fork progression through damaged DNA by the Mec1/Rad53 checkpoint. Nature. 412:2001;553-557.
53. Thorland E.C., Myers S.L., Persing D.H., Sarkar G., McGovern R.M., Gostout B.S., Smith D.I. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res. 60:2000;5916-5921.
54. Tibbetts R.S., Brumbaugh K.M., Williams J.M., Sarkaria J.N., Cliby W.A., Shieh S.-Y., Taya Y., Prives C., Abraham R.T. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:1999;152-157.
55. Tibbetts R.S., Cortez D., Brumbaugh K.M., Scully R., Livingston D., Elledge S.J., Abraham R.T. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14:2000;2989-3002.
56. Wang L., Paradee W., Mullins C., Shridhar R., Rosati R., Wilke C.M., Glover T.W., Smith D.I. Aphidicolin-induced FRA3B breakpoints cluster in two distinct regions. Genomics. 41:1997;485-488.
57. Wang L., Darling J., Zhang J.-S., Huang H., Liu W., Smith D.I. Allele-specific late replication and fragility of the most active common fragile site, FRA3B. Hum. Mol. Genet. 8:1999;431-437.
58. Ward I.M., Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276:2001;47759-47762.
59. Weinert T.A., Kiser G.L., Hartwell L.H. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev. 8:1994;652-665.
60. Wilke C.M., Hall B.K., Hoge A., Paradee W., Smith D.I., Glover T.W. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site. direct evidence for the coincidence of viral integration sites and fragile sites Hum. Mol. Genet. 5:1996;187-195.
61. Wright J., Teraoka S., Onengut S., Tolun A., Gatti R.A., Ochs H.D., Concannon P. A high frequency of distinct ATM gene mutations in ataxia-telangiectasia. Am. J. Hum. Genet. 59:1996;839-846.
62. Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., Brody L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30:2002;285-289.
63. Yunis J.J., Soreng A.L. Constitutive fragile sites and cancer. Science. 226:1984;1199-1204.
64. Zhao H., Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 21:2001;4129-4139.